FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2335650744> ?p ?o ?g. }

• W2335650744 endingPage "24360" @default.
• W2335650744 startingPage "24348" @default.
• W2335650744 abstract "// Rong-Rong Liu 1, * , Ya-Su Lv 1, * , Yue-Xiao Tang 1 , Yan-Fang Wang 1 , Xiao-Ling Chen 2 , Xiao-Xiao Zheng 1 , Shang-Zhi Xie 1 , Ying Cai 1 , Jun Yu 3 , Xian-Ning Zhang 1 1 Department of Cell Biology and Medical Genetics, Research Center for Molecular Medicine, National Education Base for Basic Medical Sciences, Institute of Cell Biology, Zhejiang University School of Medicine, Hangzhou, 310058, China 2 Department of Biological Chemistry, Zhejiang Chinese Medical University, Hangzhou, 310053, China 3 Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Key Laboratory of Multi-Organ Transplantation of Ministry of Public Health, Hangzhou, 310003, China * These authors contributed equally to this work Correspondence to: Xian-Ning Zhang, e-mail: zhangxianing@zju.edu.cn Jun Yu, e-mail: Dr.yujun@gmail.com Keywords: eukaryotic translation initiation factor 5A2, reactive oxygen species, epithelial-mesenchymal transition, migration, hepatocellular carcinoma Received: September 24, 2015      Accepted: February 28, 2016      Published: March 23, 2016 ABSTRACT Eukaryotic translation initiation factor 5A2 ( eIF5A2 ) has been identified as a critical gene in tumor metastasis. Research has suggested that reactive oxygen species (ROS) serve as signaling molecules in cancer cell proliferation and migration. However, the mechanisms linking eIF5A2 and ROS are not fully understood. Here, we investigated the effects of ROS on the eIF5A2-induced epithelial-mesenchymal transition (EMT) and migration in six hepatocellular carcinoma (HCC) cell lines. Western hybridization, siRNA transfection, transwell migration assays, wound-healing assays, and immunofluorescence analysis were used. The protein levels of eIF5A2 in tumor and adjacent tissue samples from 90 HCC patients with detailed clinical, pathological, and clinical follow-up data were evaluated. Overexpression of eIF5A2 was found in cancerous tissues compared with adjacent tissues. We found that eIF5A2 overexpression in HCC was associated with reduced overall survival. Knockdown of eIF5A2 and intracellular reduction of ROS significantly suppressed the invasion and metastasis of HCC cells. Interestingly, N1-guanyl-1, 7-diaminoheptane (GC7) suppressed the intracellular ROS levels. After blocking the EMT, administration of GC7 or N-acetyl-L-cysteine did not reduce cell migration further. Based on the experimental data, we concluded that inhibition of eIF5A2 alters progression of the EMT to decrease the invasion and metastasis of HCC cells via ROS-related pathways." @default.
• W2335650744 created "2016-06-24" @default.
• W2335650744 creator A5000694919 @default.
• W2335650744 creator A5004443237 @default.
• W2335650744 creator A5010324354 @default.
• W2335650744 creator A5014426597 @default.
• W2335650744 creator A5018428245 @default.
• W2335650744 creator A5022349567 @default.
• W2335650744 creator A5027835607 @default.
• W2335650744 creator A5031311450 @default.
• W2335650744 creator A5033822228 @default.
• W2335650744 creator A5056236904 @default.
• W2335650744 date "2016-03-23" @default.
• W2335650744 modified "2023-10-17" @default.
• W2335650744 title "Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species" @default.
• W2335650744 cites W1079999522 @default.
• W2335650744 cites W1522977578 @default.
• W2335650744 cites W1691015430 @default.
• W2335650744 cites W1759734542 @default.
• W2335650744 cites W1792622072 @default.
• W2335650744 cites W1915885637 @default.
• W2335650744 cites W1963501822 @default.
• W2335650744 cites W1964081206 @default.
• W2335650744 cites W1967005799 @default.
• W2335650744 cites W1977983510 @default.
• W2335650744 cites W1986440776 @default.
• W2335650744 cites W1988655372 @default.
• W2335650744 cites W2019834045 @default.
• W2335650744 cites W2020732208 @default.
• W2335650744 cites W2025647419 @default.
• W2335650744 cites W2037550202 @default.
• W2335650744 cites W2061031248 @default.
• W2335650744 cites W2071565875 @default.
• W2335650744 cites W2080119127 @default.
• W2335650744 cites W2081730542 @default.
• W2335650744 cites W2089159448 @default.
• W2335650744 cites W2092909221 @default.
• W2335650744 cites W2094700934 @default.
• W2335650744 cites W2104368545 @default.
• W2335650744 cites W2109202667 @default.
• W2335650744 cites W2125544618 @default.
• W2335650744 cites W2127215985 @default.
• W2335650744 cites W2128453465 @default.
• W2335650744 cites W2131359296 @default.
• W2335650744 cites W2137499622 @default.
• W2335650744 cites W2142641037 @default.
• W2335650744 cites W2167005345 @default.
• W2335650744 cites W2917837889 @default.
• W2335650744 doi "https://doi.org/10.18632/oncotarget.8324" @default.
• W2335650744 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5029706" @default.
• W2335650744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27028999" @default.
• W2335650744 hasPublicationYear "2016" @default.
• W2335650744 type Work @default.
• W2335650744 sameAs 2335650744 @default.
• W2335650744 citedByCount "24" @default.
• W2335650744 countsByYear W23356507442017 @default.
• W2335650744 countsByYear W23356507442019 @default.
• W2335650744 countsByYear W23356507442020 @default.
• W2335650744 countsByYear W23356507442021 @default.
• W2335650744 countsByYear W23356507442022 @default.
• W2335650744 countsByYear W23356507442023 @default.
• W2335650744 crossrefType "journal-article" @default.
• W2335650744 hasAuthorship W2335650744A5000694919 @default.
• W2335650744 hasAuthorship W2335650744A5004443237 @default.
• W2335650744 hasAuthorship W2335650744A5010324354 @default.
• W2335650744 hasAuthorship W2335650744A5014426597 @default.
• W2335650744 hasAuthorship W2335650744A5018428245 @default.
• W2335650744 hasAuthorship W2335650744A5022349567 @default.
• W2335650744 hasAuthorship W2335650744A5027835607 @default.
• W2335650744 hasAuthorship W2335650744A5031311450 @default.
• W2335650744 hasAuthorship W2335650744A5033822228 @default.
• W2335650744 hasAuthorship W2335650744A5056236904 @default.
• W2335650744 hasBestOaLocation W23356507441 @default.
• W2335650744 hasConcept C121608353 @default.
• W2335650744 hasConcept C126322002 @default.
• W2335650744 hasConcept C185592680 @default.
• W2335650744 hasConcept C2778019345 @default.
• W2335650744 hasConcept C2779013556 @default.
• W2335650744 hasConcept C48349386 @default.
• W2335650744 hasConcept C502942594 @default.
• W2335650744 hasConcept C55493867 @default.
• W2335650744 hasConcept C71924100 @default.
• W2335650744 hasConcept C76419328 @default.
• W2335650744 hasConceptScore W2335650744C121608353 @default.
• W2335650744 hasConceptScore W2335650744C126322002 @default.
• W2335650744 hasConceptScore W2335650744C185592680 @default.
• W2335650744 hasConceptScore W2335650744C2778019345 @default.
• W2335650744 hasConceptScore W2335650744C2779013556 @default.
• W2335650744 hasConceptScore W2335650744C48349386 @default.
• W2335650744 hasConceptScore W2335650744C502942594 @default.
• W2335650744 hasConceptScore W2335650744C55493867 @default.
• W2335650744 hasConceptScore W2335650744C71924100 @default.
• W2335650744 hasConceptScore W2335650744C76419328 @default.
• W2335650744 hasIssue "17" @default.
• W2335650744 hasLocation W23356507441 @default.
• W2335650744 hasLocation W23356507442 @default.
• W2335650744 hasLocation W23356507443 @default.
• W2335650744 hasLocation W23356507444 @default.

• next